- Clinical studies of dapagliflozin in pediatric patients: a rapid review
-
Grube PM, Beckett RD
- KMID: 2537238
- Ann Pediatr Endocrinol Metab.
- 2022 Dec;27(4):265-272.
- doi: 10.6065/apem.2244166.083
The oral sodium-glucose cotransporter 2 inhibitor, dapagliflozin, is used to treat kidney disease, heart failure, and diabetes in adults, but has not been well studied in pediatrics, and does not... -
- CITED
-
- Close
- SHARE
-
- Close
